Takeru Urayama

Title: Takeru Urayama: Innovator in Virus-Free Plasma Protein Compositions

Introduction

Takeru Urayama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of plasma protein compositions, particularly in developing methods to ensure their safety from viral contamination. His innovative approach has the potential to enhance the safety of medical treatments involving plasma proteins.

Latest Patents

Urayama holds a patent for "Virus-free plasma protein compositions treated with porous membrane and process for producing the same." This invention addresses the challenge of removing contaminant viruses from plasma protein compositions without compromising their activity. By utilizing a porous membrane with a pore size greater than the virus's single-particle size, Urayama's method allows for efficient virus removal. This process is particularly effective for fibrinogen compositions, ensuring they are substantially free of non-enveloped viruses, such as Parvovirus. The application of this invention provides a safe plasma protein preparation that is free of viruses.

Career Highlights

Throughout his career, Takeru Urayama has worked with prominent companies in the medical field, including Mitsubishi Pharma Corporation and Asahi Kasei Medical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions for plasma protein safety.

Collaborations

Urayama has collaborated with notable colleagues, including Tsuyoshi Takahashi and Koji Furushima. Their combined efforts have further advanced the research and development of safe plasma protein compositions.

Conclusion

Takeru Urayama's work in the field of virus-free plasma protein compositions represents a significant advancement in medical safety. His innovative methods and collaborations have the potential to improve the quality of plasma protein preparations, ultimately benefiting patient care.